Cargando…
Impact of effective prevention and management of febrile neutropenia
Chemotherapy-induced febrile neutropenia is costly in both financial and human terms. The associated costs can be reduced substantially through the development and implementation of national policies and locally agreed protocols for the prevention and management of febrile neutropenia. Patients, the...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752228/ https://www.ncbi.nlm.nih.gov/pubmed/19756004 http://dx.doi.org/10.1038/sj.bjc.6605273 |
_version_ | 1782172284572663808 |
---|---|
author | Krell, D Jones, A L |
author_facet | Krell, D Jones, A L |
author_sort | Krell, D |
collection | PubMed |
description | Chemotherapy-induced febrile neutropenia is costly in both financial and human terms. The associated costs can be reduced substantially through the development and implementation of national policies and locally agreed protocols for the prevention and management of febrile neutropenia. Patients, the NHS, healthcare professionals and the broader community all stand to benefit from a commitment to effective management of this common and predictable side effect of some chemotherapy regimens for early-stage breast cancer. |
format | Text |
id | pubmed-2752228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-27522282010-09-01 Impact of effective prevention and management of febrile neutropenia Krell, D Jones, A L Br J Cancer Full Paper Chemotherapy-induced febrile neutropenia is costly in both financial and human terms. The associated costs can be reduced substantially through the development and implementation of national policies and locally agreed protocols for the prevention and management of febrile neutropenia. Patients, the NHS, healthcare professionals and the broader community all stand to benefit from a commitment to effective management of this common and predictable side effect of some chemotherapy regimens for early-stage breast cancer. Nature Publishing Group 2009-09 2009-09-15 /pmc/articles/PMC2752228/ /pubmed/19756004 http://dx.doi.org/10.1038/sj.bjc.6605273 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Full Paper Krell, D Jones, A L Impact of effective prevention and management of febrile neutropenia |
title | Impact of effective prevention and management of febrile neutropenia |
title_full | Impact of effective prevention and management of febrile neutropenia |
title_fullStr | Impact of effective prevention and management of febrile neutropenia |
title_full_unstemmed | Impact of effective prevention and management of febrile neutropenia |
title_short | Impact of effective prevention and management of febrile neutropenia |
title_sort | impact of effective prevention and management of febrile neutropenia |
topic | Full Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752228/ https://www.ncbi.nlm.nih.gov/pubmed/19756004 http://dx.doi.org/10.1038/sj.bjc.6605273 |
work_keys_str_mv | AT krelld impactofeffectivepreventionandmanagementoffebrileneutropenia AT jonesal impactofeffectivepreventionandmanagementoffebrileneutropenia |